Migraine/Headache

Cards (46)

  • Migraines are more common in females than males
  • Young people tend to get migraines more often, less common in the 60s-70s
  • An aura occurs in around 30% of migraine patients
  • Migraine triggers
    • Stress
    • Meal-skipping (consider food insecurity)
    • Foods (e.g. chocolate or soft cheese)
    • Alcohol (especially red wine)
    • Caffeine withdrawal
    • Dehydration
    • Menstruation
    • Lights/sunlight
    • Erratic sleep/shift work
    • Perfume/odour
    • Obesity
    • Change in barometric pressure
  • Standard therapies & combos
    • Naproxen 500-825mg: 45% pain relief at 2 hours vs placebo 28% (NNT=5.8)
    • Acetaminophen: 52% pain relief at 2 hours vs placebo 32% (NNT=5)
    • Ibuprofen 400mg: 57% pain relief at 2 hours vs placebo 25% (NNT=3.1)
    • Oral triptan, standard dose: 57% pain relief at 2 hours vs placebo 32% (NNT=4)
    • NSAID + oral triptan: 58% pain relief at 2 hours vs placebo
  • Simplified pathophysiology of a migraine
    1. Some people have sensitized neurons - unclear why
    2. A migraine trigger comes along (e.g. stress, dehydration, lack of sleep, or completely unidentifiable)
    3. The brain releases potent vasodilators (e.g. CGRP, nitric oxide) and inflammation reactions
    4. Vasodilation = big pain; inflammation begets more inflammation
    5. Triptans = selective serotonin agonists = vasoconstrictors
    6. NSAIDs = anti-inflammation
    7. Anti-CGRP = prevent/reduce vasodilation
    8. Early treatment = nip it in the bud = better efficacy
  • Migraine Aura possible symptoms
    • Visual Aura (e.g. flickering bright lines, blind spots, lightning bolts)
    • Sensory Disturbances (e.g. tingling, numbness, pins and needles)
    • Speech Disturbances (e.g. difficulty word-finding)
  • Medications for migraine relief
    • Naproxen 500-825mg
    • Acetaminophen
    • Ibuprofen 400mg
    • Oral triptan, standard dose
    • NSAID + oral triptan
    • Oral triptan, high dose
    • Acet 1000mg + metoclop
    • Intranasal triptan, high dose
    • Subcut sumatriptan
    • Acet500 + ASA500 + caffeine130
  • Opioids have double the risk of medication overuse headache compared to other agents
  • Codeine metabolism is unpredictable
  • Triptans are potent vasoconstrictors
  • Triptans can cause chest discomfort/tightness, palpitations, dizziness, facial flushing
  • Triptans are contraindicated in cardiovascular disease and within 24 hours of ergots
  • Triptans are potent serotonin agonists
  • Triptans can cause nausea
  • Triptans are contraindicated with MAOIs and cautioned with other serotonin drugs
  • The highest efficacy triptan is subcutaneous sumatriptan
  • Try a triptan for 3 migraines before giving up, and try at least 3 triptans before giving up on the class
  • Acetaminophen alone or in combination can be helpful for migraines
  • Nausea/vomiting is common with migraines
  • ODT triptans are no faster than regular tabs
  • Max days per month of acute medications to help avoid medication overuse headache
    • Triptans: 9 days
    • Opioids: 9 days
    • NSAIDs or acetaminophen: 1-4 days
    • Multiple classes: 9 days
  • For some, migraines increase during menstruation
  • Option for pre-treatment for menstrual migraines starting ~2 days before
  • Max days per month of acute medications to help avoid medication overuse headache
    • Triptans: 9
    • Opioids: 9
    • NSAIDs or acetaminophen: 1-4
    • Multiple classes: 9
  • Menstrual migraine: For some, migraines occur during menstruation (perhaps due to changing hormone levels)
  • Option for pre-treatment during menstruation
    1. Naproxen 500mg BID x ~6 days ($5)
    2. Naratriptan 1mg BID x ~6 days ($100)
    3. Frovatriptan 2.5mg BID x ~6 days ($200)
    4. Estradiol gel 1.5mg daily x ~7 days ($40)
  • Option for prevention with continuous combined hormonal contraceptives. However, CHCs + migraine with aura are contraindicated
  • CHCs + migraine with aura + smoking
    7x stroke risk
  • New 'pants' for acute migraine: CGRP receptor antagonists
  • New CGRP medications
    • Ubrogepant approved in Canada 2022
    • Rimegepant and Zavegepant approved in USA (not yet in Canada)
    • Atogepant approved in Canada for prevention of migraines
  • Treatment dose for Ubrogepant
    50-100mg stat; NNT=8 vs placebo
  • Prevention dose for Atogepant 10 - 60 mg daily
  • Adverse effects of Atogepant: nausea, somnolence. Not contraindicated in CV disease. Likely NOT as effective as triptan for acute migraine, although not compared head-to-head. Appears to have very low risk of medication-overuse headache
  • Migraine (with or without aura):
    • duration: 4 - 72 hours
    • location: Typically unilateral (but 40% bilateral)
    • pain: Usually pulsating pain; moderate to severe intensity,
    • symptoms, patients experience at least one of: nausea, vomiting, photophobia, and/or phonophobia. Can be aggravated by routine physical activity.
  • Symptoms of moderate to severe intensity headache
    • Nausea
    • Vomiting
    • Photophobia
    • Phonophobia
  • Aura

    May include reversible visual symptoms (e.g. flickering lights, spots, or lines; loss of vision), reversible sensory symptoms (e.g. pins & needles, numbness), or reversible dysphasic speech disturbance. Each aura symptom may last 5-60 minutes
  • Treatment options for migraines
    • NSAID
    • Triptan
    • Acetaminophen
    • Anti-emetic
    • DHE
  • Prophylaxis options for migraines:
    • TCA
    • Beta-blocker
    • Topiramate
    • Candesartan
    • Venlafaxine
    • Anti-CGRP
    • Some herbals
  • Tension-Type headache lasts from 30 minutes to 7 days